BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3358118)

  • 1. Aluminum toxicity to the brain.
    Krishnan SS; McLachlan DR; Krishnan B; Fenton SS; Harrison JE
    Sci Total Environ; 1988 Apr; 71(1):59-64. PubMed ID: 3358118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content of brain aluminum is not elevated in Alzheimer disease.
    Bjertness E; Candy JM; Torvik A; Ince P; McArthur F; Taylor GA; Johansen SW; Alexander J; Grønnesby JK; Bakketeig LS; Edwardson JA
    Alzheimer Dis Assoc Disord; 1996; 10(3):171-4. PubMed ID: 8876778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum and Alzheimer's disease.
    McLachlan DR
    Neurobiol Aging; 1986; 7(6):525-32. PubMed ID: 3550508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry.
    Jacobs RW; Duong T; Jones RE; Trapp GA; Scheibel AB
    Can J Neurol Sci; 1989 Nov; 16(4 Suppl):498-503. PubMed ID: 2804812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser microprobe analysis of brain aluminum in Alzheimer's disease.
    Lovell MA; Ehmann WD; Markesbery WR
    Ann Neurol; 1993 Jan; 33(1):36-42. PubMed ID: 8257483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease.
    Yumoto S; Kakimi S; Ohsaki A; Ishikawa A
    J Inorg Biochem; 2009 Nov; 103(11):1579-84. PubMed ID: 19744735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminum levels in brain in Alzheimer's disease.
    Trapp GA; Miner GD; Zimmerman RL; Mastri AR; Heston LL
    Biol Psychiatry; 1978 Dec; 13(6):709-18. PubMed ID: 737258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for participation of aluminum in neurofibrillary tangle formation and growth in Alzheimer's disease.
    Walton JR
    J Alzheimers Dis; 2010; 22(1):65-72. PubMed ID: 20847423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR
    J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients.
    Harrington CR; Wischik CM; McArthur FK; Taylor GA; Edwardson JA; Candy JM
    Lancet; 1994 Apr; 343(8904):993-7. PubMed ID: 7909090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.
    Markesbery WR; Ehmann WD; Hossain TI; Alauddin M; Goodin DT
    Ann Neurol; 1981 Dec; 10(6):511-6. PubMed ID: 7325600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum and Alzheimer's disease: a new look.
    Miu AC; Benga O
    J Alzheimers Dis; 2006 Nov; 10(2-3):179-201. PubMed ID: 17119287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
    Tabaton M; Whitehouse PJ; Perry G; Davies P; Autilio-Gambetti L; Gambetti P
    Ann Neurol; 1988 Sep; 24(3):407-13. PubMed ID: 3067653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical biochemistry of aluminum.
    King SW; Savory J; Wills MR
    Crit Rev Clin Lab Sci; 1981; 14(1):1-20. PubMed ID: 7016437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain aluminum in Alzheimer's disease using an improved GFAAS method.
    Xu N; Majidi V; Markesbery WR; Ehmann WD
    Neurotoxicology; 1992; 13(4):735-43. PubMed ID: 1302300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the association of protein 4.1 immunoreactive forms with neurofibrillary tangles in Alzheimer's disease brains.
    Sihag RK; Wang LW; Cataldo AM; Hamlin M; Cohen CM; Nixon RA
    Brain Res; 1994 Sep; 656(1):14-26. PubMed ID: 7804827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
    Jeynes B; Provias J
    Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.